6.635USD+0.68%Mkt Cap: 45.43M USDP/E: 0.31Last update: 2026-05-26
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rh…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap45.43M USD
Enterprise Value32.89M USD
Revenue (TTM)5.18M USD
Gross Profit-3.20M USD
Net Income (TTM)-22.39M USD
Revenue/Share1.120 USD
Last Price6.635 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees28
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS72941H4002
Valuation
P/E (Trailing)0.31
P/E (Forward)-2.91
PEG2.45
EV/EBITDA-1.78
EV/Revenue6.35
P/S9.15
P/B3.95
EPS (TTM)21.56
EPS (Forward)-2.37
52W Range
2.90018% of range23.50
52W High23.50 USD
52W Low2.900 USD
Profitability
Gross Margin-61.69%
Oper. Margin-692.51%
EBITDA Margin0.00%
Profit Margin-230.24%
ROE-560.21%
ROA-137.13%
Growth
Revenue Growth-2.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.77M USD
CapEx (TTM)67.00K USD
FCF Margin-308.21%
FCF Yield-35.16%
Net Debt-14.39M USD
Net Debt/EBITDA0.78
Balance Sheet
Debt/Equity0.21
Current Ratio2.27
Quick Ratio2.07
Book Value/Sh1.743 USD
Cash/Share2.203 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 6, 2019
Splits
Last Split1:25
Split DateApr 2, 2026
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)38.00 USD
Target Range12.00 USD – 65.00 USD
# Analysts4
Ownership
Shares Out.6.88M
Float6.33M
Insiders1.45%
Institutions17.60%
Short Interest
Short Ratio2.1d
Short % Float18.04%
Short % Out.17.97%
Shares Short1.23M
Short (prev mo.)957.31K
Technical
SMA 505.763 (+15.1%)
SMA 20010.74 (-38.2%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)223.17K
Avg Vol (10d)171.66K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—